Nasdaq Hearings Panel determined to delist Nuvve Holding Corp.
On July 22, 2026, the Nasdaq Hearings Panel issued a delisting determination against Nuvve Holding Corp., citing the company's failure to comply with the periodic reporting requirement (Form 10-Q for the quarter ended March 31, 2026), the $1.00 minimum bid price rule, and the $2,500,000 stockholders' equity requirement. Trading in the company's common stock was suspended effective July 24, 2026. The company has 15 days to appeal the determination to the Nasdaq Listing and Hearing Review Council and expects its stock to begin trading on the Pink Limited Information Tier of the OTC Markets under the symbol "NVVE" starting July 24, 2026.
- Nasdaq Hearings Panel delisting determination issued July 22, 2026
- Non-compliance with Nasdaq Listing Rule 5250(c)(1) periodic reporting requirement (Form 10-Q for quarter ended March 31, 2026)
- Non-compliance with Nasdaq Listing Rule 5550(a)(1) $1.00 minimum bid price requirement
- Non-compliance with Nasdaq Listing Rule 5550(b)(1) $2,500,000 stockholders' equity requirement
- Trading suspended effective July 24, 2026
- Company may appeal within 15 days under Nasdaq Listing Rule 5820
- Stock expected to begin trading on Pink Limited Information Tier of OTC Markets effective July 24, 2026
Nuvve's delisting from Nasdaq Capital Market results in immediate suspension of trading on the exchange and marks a material downgrade in the company's listing status; while the company has appeal rights and is moving to OTC trading, the delisting determination represents a significant loss of exchange visibility and liquidity.
- NT 10-Q
- 8-Kthis filing
Derived from 8-K filed 2026-07-23. Not investment advice. Figures are extracted from the filing; prose is AI-assisted. View the source filing on SEC.gov →